Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Fujii

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerJunzo Hamanishi, Masaki Mandai, Masashi Iwasaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 21, 2003
Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervixChie Kuragaki, Takayuki Enomoto, Yuko Ueno, et al.
International Journal of Cancer|October 2, 2009
Targeting slow-proliferating ovarian cancer cellsEiji Kondoh, Seiichi Mori, Ken Yamaguchi, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Dormant Ovarian Cancer Cells <i>In Vitro</i> and in an <i>In Vivo</i> Mouse Model of Platinum ResistanceZhiqing Huang, Eiji Kondoh, Zachary R Visco, et al.
Annals of Nuclear Medicine|July 9, 2003
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancerTsuneo Saga, Tatsuya Higashi, Takayoshi Ishimori, et al.
Japanese Journal of Clinical Oncology|August 24, 2006
Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapyKiichiro Noda, Yasuo Ohashi, Hiroji Okada, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
International Journal of Cancer|July 31, 2009
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancerPaula S Lee, Vanessa S Teaberry, Amy E Bland, et al.
Biochemical and Biophysical Research Communications|June 29, 2007
Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivityTsukasa Baba, Seiichi Mori, Noriomi Matsumura, et al.
Molecular Human Reproduction|October 17, 2003
PEP-19 overexpression in human uterine leiomyomaTakanobu Kanamori, Kenji Takakura, Masaki Mandai, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerJunzo Hamanishi, Masaki Mandai, Masashi Iwasaki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 21, 2003
Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervixChie Kuragaki, Takayuki Enomoto, Yuko Ueno, et al.
International Journal of Cancer|October 2, 2009
Targeting slow-proliferating ovarian cancer cellsEiji Kondoh, Seiichi Mori, Ken Yamaguchi, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Dormant Ovarian Cancer Cells <i>In Vitro</i> and in an <i>In Vivo</i> Mouse Model of Platinum ResistanceZhiqing Huang, Eiji Kondoh, Zachary R Visco, et al.
Annals of Nuclear Medicine|July 9, 2003
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancerTsuneo Saga, Tatsuya Higashi, Takayoshi Ishimori, et al.
Japanese Journal of Clinical Oncology|August 24, 2006
Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapyKiichiro Noda, Yasuo Ohashi, Hiroji Okada, et al.
Gynecologic Oncology|December 17, 2009
Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotypeJason C Barnett, Sarah M Bean, Regina S Whitaker, et al.
International Journal of Cancer|July 31, 2009
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancerPaula S Lee, Vanessa S Teaberry, Amy E Bland, et al.
Biochemical and Biophysical Research Communications|June 29, 2007
Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivityTsukasa Baba, Seiichi Mori, Noriomi Matsumura, et al.
Molecular Human Reproduction|October 17, 2003
PEP-19 overexpression in human uterine leiomyomaTakanobu Kanamori, Kenji Takakura, Masaki Mandai, et al.
Pageof 16